COVID-19 (death) |
Treatment |
Treatment for COVID-19 [Treated with dexamethasone vs. Usual care] |
Risk ratio: 0.830 (0.740-0.920)
§ |
Horby
|
|
|
COVID-19 (death) |
Treatment |
Treatment for COVID-19 [Treated with corticosteroid vs. Not received] |
Hazard ratio: 2.300 (1.000-5.290)
|
Ye
|
|
|
COVID-19 (death) |
Treatment |
Treatment for COVID-19 [Treated with corticosteroid vs. Not received] |
Hazard ratio: 0.410 (0.200-0.830)
|
Ye
|
|
|
SARS COV-2 infection |
Symptoms |
Symptomatic SARS COV-2 infection [Present vs. Not present] |
Odds ratio: 1.212 (0.522-2.815)
|
Yin
|
|
|
SARS COV-2 infection |
Symptoms |
Symptomatic SARS COV-2 infection [Present vs. Not present] |
Odds ratio: 1.568 (0.679-3.620)
|
Yin
|
|
|
COVID-19 (death) |
Patient characteristics |
Gender [Male vs. Female] |
Hazard ratio: 0.920 (0.770-1.110)
§ |
Petrilli
|
|
|
COVID-19 (death) |
Patient characteristics |
Age [>=75 years vs. 19-44 years] |
Hazard ratio: 7.690 (4.600-12.840)
§ |
Petrilli
|
|
|
COVID-19 (death) |
Patient characteristics |
Age [65-74 years vs. 19-44 years] |
Hazard ratio: 4.830 (2.930-7.960)
§ |
Petrilli
|
|
|
COVID-19 (death) |
Patient characteristics |
Age [55-64 years vs. 19-44 years] |
Hazard ratio: 3.180 (1.930-5.210)
§ |
Petrilli
|
|
|
COVID-19 (death) |
Patient characteristics |
Age [45-54 years vs. 19-44 years] |
Hazard ratio: 1.950 (1.160-3.310)
§ |
Petrilli
|
|
|
COVID-19 (severe/critical) |
Laboratory Findings |
Lymphopenia at hospital admission [Present vs. Not present] |
Odds ratio: 2.990 (1.310-6.820)
|
Zhao
|
|
|
COVID-19 (death) |
Laboratory Findings |
D-dimer [Abnormal at admission vs. Normal] |
Hazard ratio: 22.400 (2.860-175.700)
§ |
Zhang
|
|
|
COVID-19 (death) |
Comorbidities |
Immunocompromised [Present vs. Not present] |
Hazard ratio: 1.690 (1.210-2.340)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Comorbidities |
Autoimmune diseases [Present vs. Not present] |
Hazard ratio: 1.230 (1.120-1.350)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Comorbidities |
Spleen diseases [Present vs. Not present] |
Hazard ratio: 1.410 (0.930-2.120)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Comorbidities |
Organ transplantation [Yes vs. No] |
Hazard ratio: 4.270 (3.200-5.700)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Comorbidities |
Kidney disease [Present vs. Not present] |
Hazard ratio: 1.720 (1.620-1.830)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Comorbidities |
other neurological diseases [Present vs. Not present] |
Hazard ratio: 2.460 (2.190-2.760)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Comorbidities |
Stroke/dementia [Present vs. Not present] |
Hazard ratio: 1.790 (1.670-1.930)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Comorbidities |
Liver disease [Present vs. Not present] |
Hazard ratio: 1.610 (1.330-1.950)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Comorbidities |
Haematological malignancy [Present vs. Not present] |
Hazard ratio: 1.880 (1.550-2.290)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Comorbidities |
Haematological malignancy [Present vs. Not present] |
Hazard ratio: 3.120 (2.500-3.890)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Comorbidities |
Haematological malignancy [Present vs. Not present] |
Hazard ratio: 3.520 (2.410-5.140)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Comorbidities |
Non-hematologic Cancer [Present vs. Not present] |
Hazard ratio: 0.970 (0.880-1.060)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Comorbidities |
Non-hematologic Cancer [Present vs. Not present] |
Hazard ratio: 1.190 (1.040-1.350)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Comorbidities |
Non-hematologic Cancer [Present vs. Not present] |
Hazard ratio: 1.560 (1.290-1.890)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Comorbidities |
Diabetes [Present vs. Not present] |
Hazard ratio: 1.870 (1.630-2.160)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Comorbidities |
Diabetes [Present vs. Not present] |
Hazard ratio: 2.360 (2.180-2.560)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Comorbidities |
Diabetes [Present vs. Not present] |
Hazard ratio: 1.500 (1.400-1.600)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Comorbidities |
Chronic heart disease [Present vs. Not present] |
Hazard ratio: 1.270 (1.200-1.350)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Comorbidities |
Asthma [Present vs. Not present] |
Hazard ratio: 1.250 (1.080-1.440)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Comorbidities |
Asthma [Present vs. Not present] |
Hazard ratio: 1.110 (1.020-1.200)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Comorbidities |
Respiratory disease [Present vs. Not present] |
Hazard ratio: 1.780 (1.670-1.900)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Comorbidities |
Hypertension [Present vs. Not present] |
Hazard ratio: 0.950 (0.890-1.010)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Other |
Economic regions [IMD 5th quintile vs. IMD 1st quintile] |
Hazard ratio: 1.750 (1.600-1.910)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Other |
Economic regions [IMD 4th quintile vs. IMD 1st quintile] |
Hazard ratio: 1.490 (1.370-1.630)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Other |
Economic regions [IMD 3rd quintile vs. IMD 1st quintile] |
Hazard ratio: 1.230 (1.130-1.350)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Other |
Economic regions [IMD 2nd quintile vs. IMD 1st quintile] |
Hazard ratio: 1.130 (1.040-1.240)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Patient characteristics |
Ethnicity [Other vs. White] |
Hazard ratio: 1.330 (1.030-1.730)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Patient characteristics |
Ethnicity [Black vs. White] |
Hazard ratio: 1.710 (1.440-2.020)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Patient characteristics |
Ethnicity [Asian vs. White] |
Hazard ratio: 1.620 (1.430-1.820)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Patient characteristics |
Ethnicity [Mixed vs. White] |
Hazard ratio: 1.640 (1.190-2.260)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Patient characteristics |
Smoking [Present vs. No history of smoking] |
Hazard ratio: 0.880 (0.790-0.990)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Patient characteristics |
Smoking [History of smoking vs. No history of smoking] |
Hazard ratio: 1.250 (1.180-1.330)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Patient characteristics |
BMI [Severe obesity (>40kg/m2) vs. Non-obese (BMI<30)] |
Hazard ratio: 2.270 (1.990-2.580)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Patient characteristics |
BMI [Severe obesity (35-40kg/m2) vs. Non-obese (BMI<30)] |
Hazard ratio: 1.560 (1.410-1.730)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Patient characteristics |
BMI [Obesity (30-35kg/m2) vs. Non-obese (BMI<30)] |
Hazard ratio: 1.270 (1.180-1.360)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Patient characteristics |
Gender [Male vs. Female] |
Hazard ratio: 1.990 (1.880-2.100)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Patient characteristics |
Age [>=80 years vs. 50-59 years] |
Hazard ratio: 12.640 (11.190-14.280)
§ |
The OpenSAFELY Collaborative
|
|
|
COVID-19 (death) |
Patient characteristics |
Age [70-79 years vs. 50-59 years] |
Hazard ratio: 4.770 (4.230-5.380)
§ |
The OpenSAFELY Collaborative
|
|
|